Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo
Caroline D. Scatena, Jeffrey L. Kumer, Jennifer P. Arbitrario, Anthony R. Howlett, Rachael E. Hawtin, Judith A. Fox, Jeffrey A. SilvermanVolume:
66
Language:
english
Pages:
8
DOI:
10.1007/s00280-009-1234-z
Date:
October, 2010
File:
PDF, 501 KB
english, 2010